XBiotech Inc. (XBIT) Gross margin 2020–2022
XBiotech Inc. (XBIT) gross margin by fiscal year — reported gross profit divided by reported revenue.
83.8%FY2022 · since FY2020: 21.5% → 83.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 83.8% | +15.4 pp |
| FY2021 | 68.4% | +46.9 pp |
| FY2020 | 21.5% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More XBIT financial trends
XBIT RevenueXBIT Net incomeXBIT Net marginXBIT Gross profitXBIT Operating incomeXBIT Operating marginXBIT Operating cash flowXBIT Free cash flowXBIT Capital expendituresXBIT Return on equityXBIT Stock buybacksXBIT Dividends paidXBIT Total assetsXBIT Total liabilitiesXBIT Shareholders’ equityXBIT overview →